- Home
- CVS vs BUD Comparison
CVS vs BUD Comparison
Compare CVS & BUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CVS | BUD |
|---|---|---|
| Founded | 1963 | 1366 |
| Country | United States | Belgium |
| Employees | N/A | 136805 |
| Industry | Retail-Drug Stores and Proprietary Stores | Beverages (Production/Distribution) |
| Sector | Consumer Staples | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 133.6B | 154.4B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | CVS | BUD |
|---|---|---|
| Price | $106.19 | $81.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 18 | 3 |
| Target Price | ★ $94.72 | $92.00 |
| AVG Volume (30 Days) | ★ 6.8M | 2.2M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.17% | 1.33% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.30 | N/A |
| Revenue | ★ $402,067,000,000.00 | N/A |
| Revenue This Year | $2.36 | $8.01 |
| Revenue Next Year | $4.69 | $3.67 |
| P/E Ratio | $46.04 | ★ $23.27 |
| Revenue Growth | ★ 7.85 | N/A |
| 52 Week Low | $58.50 | $56.97 |
| 52 Week High | $107.94 | $85.56 |
Technical Indicators
Market Signals| Indicator | CVS | BUD |
|---|---|---|
| Relative Strength Index (RSI) | 65.27 | 53.42 |
| Support Level | $75.14 | $78.34 |
| Resistance Level | N/A | $82.01 |
| Average True Range (ATR) | 2.46 | 1.46 |
| MACD | -0.19 | -0.17 |
| Stochastic Oscillator | 63.91 | 42.13 |
Price Performance
Historical ComparisonAbout CVS CVS Health Corporation
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
About BUD Anheuser-Busch Inbev SA Sponsored ADR (Belgium)
Anheuser-Busch InBev is the largest brewer in the world and one of the world's top five consumer product companies, as measured by EBITDA. The company's portfolio contains six of the top 10 beer brands by volume, and we estimate it distributes 23 brands with retail sales over $1 billion. AB InBev was created by the 2008 merger of Belgium-based InBev and US-based Anheuser-Busch. The firm holds a 62% economic interest in Ambev, an 87% stake in Budweiser APAC, and in 2016 acquired SABMiller.